Ozi dị ukwuu maka CHUANGKUN BIOTECH n'ahịa mba ofesi SHANGHAI CHUANGKUN BIOTECH TB/NTM NUCLEIC ACIID DETECTION KIT(LYOPHILIZED) anabatala ndị India FDA!

N'oge na-adịbeghị anya, Shanghai Chuangkun Biotechnology Co., Ltd nwetara akwụkwọ ndebanye aha nke abụọ nke Indonesia FDA maka ngwa nchọpụta TB/NTM Nucleic Acid (lyophilized), steepụ site na (12+3) ụdị HPV nchọpụta PCR otu ọnwa gara aga.nke kwuputara na ngwaahịa Chuangkun Biotech bụ ndị Indonesia FDA nyere ikike, na-emezi ngwaahịa ndị na-emepụta onwe ha, ma na-enyekwa Chuangkun Biotech nkwado siri ike iji gbasaa ahịa mba ụwa.

Dị ka World Health Organisation's Global TB Report 2022 si kwuo, ihe dị ka nde mmadụ 10.6 ga-ebute TB na 2021. Ọnụ ọgụgụ na-abawanye site na 4.5% karịrị afọ 2020. Ka ọ dị ugbu a nde mmadụ 1.6 nwụrụ n'ihi ụkwara nta n'afọ gara aga (gụnyere 6.7% so na ya. ndị nwere nje HIV).Na mpaghara ala, ọtụtụ ọrịa TB na 2021 nọ na mpaghara WHO nke South-East Asia (45%), Africa (23%) na Western Pacific (18%), yana obere oke na Eastern Mediterranean (8.1%), America. (2.9%) na Europe (2.2%).N'ịtụle COVID-19 oria ojoo, mgbochi ụkwara nta na ịchịkwa ụkwara nta na-akawanye njọ maka atụmatụ ịkwụsị ụkwara nta maka WHO.

TB / NTM Nucleic Acid detection kit si CHUANGKUN Biotech na-emepụta site na usoro lyophilization . Usoro a ga-edozi nsogbu njem njem ogologo oge maka ihe nchọpụta PCR omenala, ma na-ewetakwa ihe ziri ezi na ihe dị elu dị elu karịa mma maka ojiji anyị.

Shanghai Chuangkun Biotechnology Co., Ltd nwetara akwụkwọ ndebanye aha nke abụọ nke Indonesia FDA maka ngwa nchọpụta TB/NTM Nucleic Acid, na-egosi nnabata Indonesia FDA.Chuangkun Biotech ga-etinye aka n'ịgbasa na mgbochi ụkwara nta mpaghara yana ịchịkwa nke ọma.